Authors:
Sanmuganathan, PS
Ghahramani, P
Jackson, PR
Wallis, EJ
Ramsay, LE
Citation: Ps. Sanmuganathan et al., Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials, HEART, 85(3), 2001, pp. 265-271
Authors:
Wallis, EJ
Ramsay, LE
Haq, IU
Ghahramani, P
Jackson, PR
Citation: Ej. Wallis et al., Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation, J HYPERTENS, 19(4), 2001, pp. 691-696
Authors:
Chong, LK
Chowdry, J
Ghahramani, P
Peachell, PT
Citation: Lk. Chong et al., Influence of genetic polymorphisms in the beta(2)-adrenoceptor on desensitization in human lung mast cells, PHARMACOGEN, 10(2), 2000, pp. 153-162
Authors:
Wallis, EJ
Ramsay, LE
Haq, IU
Ghahramani, P
Jackson, PR
Rowland-Yeo, K
Yeo, WW
Citation: Ej. Wallis et al., Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population, BR MED J, 320(7236), 2000, pp. 671-676
Citation: P. Ghahramani et al., Fraction of dose of drug converted to a metabolite when both compete for metabolism by the same enzyme, BR J CL PH, 47(5), 1999, pp. 578-578